Endovascular Therapy for Ischemic Stroke

키워드

참고문헌 (82)

1. Natarajan SK, "Endovascular treatment of acute ischemic stroke", Neuroimaging Clin N Am, 23, pp.673~694 (2013)
2. Heiss WD, "Functional recovery of cortical neurons as related to degree and duration of ischemia", Ann Neurol, 14, pp.294~301 (1983)
3. "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995), The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
4. Bivard A, "Review of stroke thrombolytics", J Stroke, 15, pp.90~98 (2013)
5. Grunwald IQ, "Endovascular stroke treatment today", AJNR Am J Neuroradiol, 32, pp.238~243 (2011)
6. Mishra SM, "Early Reperfusion Rates with IV tPA Are Determined by CTA Clot Characteristics", AJNR Am J Neuroradiol, 35, pp.2265~2272 (2014)
7. Saqqur M, "Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke", Stroke, 38, pp.948~954 (2007)
8. del Zoppo GJ, "Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke", Ann Neurol, 32, pp.78~86 (1992)
9. Bhatia R, "Combined full-dose IV and endovascular thrombolysis in acute ischaemic stroke", Int J Stroke, 9, pp.974~979 (2014)
10. Sussman BJ, "Thrombolysis with fibrinolysin in cerebral arterial occlusion", J Am Med Assoc, 167, pp.1705~1709 (1958)
11. del Zoppo GJ, "Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study", Stroke, 19, pp.307~313 (1988)
12. Hacke W, "Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease", Stroke, 19, pp.1216~1222 (1988)
13. Mori E, "Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery", Stroke, 19, pp.802~812 (1988)
14. del Zoppo GJ, "Thrombolytic intervention in acute thrombotic and embolic stroke", Semin Neurol, 11, pp.368~384 (1991)
15. Zeumer H, "Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)", Neuroradiology, 35, pp.159~162 (1993)
16. del Zoppo GJ, "PROACT: a phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism", Stroke, 29, pp.4~11 (1998)
17. Furlan A, "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism", JAMA, 282, pp.2003~2011 (1999)
18. Lewandowski CA, "Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial", Stroke, 30, pp.2598~2605 (1999)
19. IMS Study Investigators, "Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study", Stroke, 35, pp.904~911 (2004)
20. IMS II Trial Investigators, "The Interventional Management of Stroke (IMS) II Study", Stroke, 38, pp.2127~2135 (2007)
21. Broderick JP, "Endovascular therapy after intravenous t-PA versus t-PA alone for stroke", N Engl J Med, 368, pp.893~903 (2013)
22. Smith WS, "Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial", Stroke, 36, pp.1432~1438 (2005)
23. Smith WS, "Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial", Stroke, 39, pp.1205~1212 (2008)
24. Penumbra Pivotal Stroke Trial Investigators, "The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease", Stroke, 40, pp.2761~2768 (2009)
25. Struffert T, "Penumbra Stroke System as an “add-on” for the treatment of large vessel occlusive disease following thrombolysis: first results", Eur Radiol, 19, pp.2286~2293 (2009)
26. Menon BK, "Initial experience with the Penumbra Stroke System for recanalization of large vessel occlusions in acute ischemic stroke", Neuroradiology, 53, pp.261~266 (2011)
27. Kulcsár Z, "Penumbra system: a novel mechanical thrombectomy device for large-vessel occlusions in acute stroke", AJNR Am J Neuroradiol, 31, pp.628~633 (2010)
28. Ciccone A, "Endovascular treatment for acute ischemic stroke", N Engl J Med, 368, pp.904~913 (2013)
29. Kidwell CS, "Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial", Int J Stroke, 9, pp.110~116 (2014)
30. Holmes DR Jr, "Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries", J Am Coll Cardiol, 25(7), pp.10S~17S (1995)
31. Gibson CM, "Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group", Am J Cardiol, 87, pp.450~453 (2001)
32. "The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators", N Engl J Med, 329, pp.1615~1622 (1993)
33. Stone GW, "Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction", N Engl J Med, 346, pp.957~966 (2002)
34. Mehta RH, "Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention", J Am Coll Cardiol, 42, pp.1739~1746 (2003)
35. Anderson JL, "Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction", Am J Cardiol, 78, pp.1~8 (1996)
36. "An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators", N Engl J Med, 329, pp.673~682 (1993)
37. Takasawa M, "How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET", Stroke, 39, pp.870~877 (2008)
38. Fiorella D, "Assessment of the reproducibility of postprocessing dynamic CT perfusion data", AJNR Am J Neuroradiol, 25, pp.97~107 (2004)
39. Latchaw RE, "Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association", Stroke, 40, pp.3646~3678 (2009)
40. Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)
41. Davis SM, "Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial", Lancet Neurol, 7, pp.299~309 (2008)
42. Lansberg MG, "MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study", Lancet Neurol, 11, pp.860~867 (2012)
43. Turk AS, "CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study", J Neurointerv Surg, 5, pp.523~527 (2013)
44. Nguyen TN, "Vascular neurologists and neurointerventionalists on endovascular stroke care: polling results", Neurology, 79(13), pp.S5~S15 (2012)
45. von Kummer R, "Acute stroke: usefulness of early CT findings before thrombolytic therapy", Radiology, 205, pp.327~333 (1997)
46. Yoo AJ, "Impact of pretreatment noncontrast CT Alberta Stroke Program Early CT Score on clinical outcome after intra-arterial stroke therapy", Stroke, 45, pp.746~751 (2014)
47. Menon BK, "ASPECTS and other neuroimaging scores in the triage and prediction of outcome in acute stroke patients", Neuroimaging Clin N Am, 21, pp.407~423 (2011)
48. Mlynash M, "Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set", Stroke, 42, pp.1270~1275 (2011)
49. Fiebach JB, "CT and diffusion-weighted MR imaging in randomized order:diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke", Stroke, 33, pp.2206~2210 (2002)
50. Barber PA, "Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score", Lancet, 355, pp.1670~1674 (2000), ASPECTS Study Group
51. Hill MD, "Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial", Stroke, 45, pp.444~449 (2014)
52. Liebeskind DS, "Impact of collaterals on successful revascularization in Solitaire FR with the intention for thrombectomy", Stroke, 45, pp.2036~2040 (2014)
53. Yoo AJ, "MRI-based selection for intra-arterial stroke therapy:value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization", Stroke, 40, pp.2046~2054 (2009)
54. Parsons MW, "Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis", J Cereb Blood Flow Metab, 30, pp.1214~1225 (2010)
55. Fisher M, "Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator?", Ann Neurol, 60, pp.499~501 (2006)
56. Yoo AJ, "Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review", Expert Rev Cardiovasc Ther, 9, pp.857~876 (2011)
57. Kane I, "Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date", J Neurol Neurosurg Psychiatry, 78, pp.485~491 (2007)
58. Butcher KS, "Refining the perfusion-diffusion mismatch hypothesis", Stroke, 36, pp.1153~1159 (2005)
59. Menon BK, "Assessment of leptomeningeal collaterals using dynamic CT angiography in patients with acute ischemic stroke", J Cereb Blood Flow Metab, 33, pp.365~371 (2013)
60. Menon BK, "Computed Tomography Angiography in the Assessment of Patients With Stroke", TIA, 2011, pp.1, 187~199
61. Nogueira RG, "Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial", Lancet, 380, pp.1231~1240 (2012)
62. Saver JL, "Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial", Lancet, 380, pp.1241~1249 (2012)
63. Liebeskind DS, "Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial", Stroke, 45, pp.759~764 (2014)
64. Liebeskind DS, "Trials of endovascular therapies or collaterals?", Int J Stroke, 8, pp.258~259 (2013)
65. Nambiar V, "CTA collateral status and response to recanalization in patients with acute ischemic stroke", AJNR Am J Neuroradiol, 35, pp.884~890 (2014)
66. Demchuk AM, "Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial", Radiology, 273, pp.202~210 (2014)
67. Kidwell CS, "A trial of imaging selection and endovascular treatment for ischemic stroke", N Engl J Med, 368, pp.914~923 (2013)
68. Lees KR, "Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials", Lancet, 375, pp.1695~1703 (2010)
69. Marler JR, "Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study", Neurology, 55, pp.1649~1655 (2000)
70. Alexandrov AV, "Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke", N Engl J Med, 351, pp.2170~2178 (2004)
71. Khatri P, "Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial", Lancet Neurol, 13, pp.567~574 (2014)
72. Menon BK, "Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR thrombectomy for acute revascularization study", Stroke, 45, pp.2024~2029 (2014)
73. Meretoja A, "Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months", Neurology, 81, pp.1071~1076 (2013)
74. Meretoja A, "Reducing in-hospital delay to 20 minutes in stroke thrombolysis", Neurology, 79, pp.306~313 (2012)
75. Khatri P, "Good clinical outcome after ischemic stroke with successful revascularization is time-dependent", Neurology, 73, pp.1066~1072 (2009)
76. Sun CH, "“Picture to puncture”: a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke", Circulation, 127, pp.1139~1148 (2013)
77. Gupta R, "Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes", J Neurointerv Surg, 5, pp.294~297 (2013)
78. Sun CH, "Endovascular therapy for stroke: getting to the “heart” of the matter", Circulation, 129, pp.1152~1160 (2014)
79. Almekhlafi MA, "Overcoming the evening", weekend effects on time delays and outcomes of endovascular stroke therapy: the Calgary Stroke Program experience, 2014, pp.6, 729~732
80. Tomsick T, "TIMI, TIBI, TICI: I came, I saw, I got confused", AJNR Am J Neuroradiol, 28, pp.382~384 (2007)
81. Tarr R, "The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe", J Neurointerv Surg, 2, pp.341~344 (2010)
82. Shi ZS, "MERCI and Multi-MERCI Investigators. Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials", Stroke, 41, pp.953~960 (2010)

관련 논문AI추천